Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss)	$ (783,616)	$ 831,188
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	33,885	60,613
Interest expense related to amortization of non-cash discount, non-cash beneficial conversion feature and deferred financing costs	26,175
Expenses related to employee stock based compensation	7,950	74,891
Expenses related to common stock warrants issued for consulting		(1,890,816)
Non-cash fair value of common stock issued as settlement of accrued payable	43,000	128,000
Non-cash fair value of common stock issued as compensation	45,000
Non-cash fair value of preferred stock issued as compensation	37,500
Non-cash fair value of common stock in exchange for warrants	62,070
Non-cash gain on preferred stock exchanged		(330,360)
Non-cash fair value of common stock issued in connection with notes payable	81,037
Net gain on disposition of assets and investments		(1,890,816)
Net gain on settlement of accounts payable	220,329	(366,590)
Net gain on settlement of accrued compensation payable		(252,440)
(Increase) decrease in:
Accounts receivable	336	68,171
Interest receivable	(16,000)	(16,000)
Inventories	860	911
Prepaid expenses	6,286	104,819
Deposits
Security deposits	(2,000)	5,000
Increase (decrease) in:
Accounts payable		54,952
Accrued expenses	(344,011)	187,440
Deferred renvenue	(147,792)	(337,160)
Net Cash Used by Operating Activities before Discontinued Operations	(609,897)	(1,677,131)
Net Cash Provided (Used) by Discontinued Operations	182,518	(156,591)
Net Cash Used by Operating Activities	(427,379)	(1,833,722)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash proceeds from sale of investment securities		1,655,954
Cash proceeds from sale of equipment		31,501
Net Cash Provided (Used) by Investing Activities		1,687,455
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of convertible promissory notes	205,000
Net Cash Provided by Financing Activities	205,000
Net Increase (Decrease) in Cash and Cash Equivalents	(223,379)	(146,267)
Net Cash of Deconsolidated Subsidiary
Cash and Cash Equivalents, Beginning of Period	229,944	376,211
Cash and Cash Equivalents, End of Period	7,565	229,944
Supplemental Cash Flow Disclosures:
Interest expense paid in cash		7,449
Income tax paid
NON CASH INVESTING & FINANCING ACTIVITIES:
Issuance of common stock for settlement of accounts payable	$ 43,000